{"id":"W4379981642","doi":"10.1002/hon.3164_313","title":"Final analysis of Australasian Leukaemia & Lymphoma Group NHL29: A phase II study of ibrutinib, rituximab and mini‐CHOP in very elderly patients with newly diagnosed DLBCL","year":2023,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Nutrasource","funders":"Cilag","keywords":"Medicine; Ibrutinib; Rituximab; Vincristine; Internal medicine; Diffuse large B-cell lymphoma; International Prognostic Index; Prednisone; CHOP; Lymphoma; Cyclophosphamide; Gastroenterology; Surgery; Oncology; Chemotherapy; Leukemia; Chronic lymphocytic leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004955627,0.0006343322,0.001289809,0.00017887,0.0003017814,0.0005450969,0.0006869772,0.0004432322,0.002013546],"category_scores_gemma":[0.002404789,0.0003889655,0.001325481,0.0002662615,0.0003858725,0.0003017301,0.0005278295,0.0008789403,0.0004837732],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005384376,"about_ca_system_score_gemma":0.001422843,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009464798,"about_ca_topic_score_gemma":0.002151262,"domain_scores_codex":[0.9986668,0.0009038369,0.00008752977,0.000143639,0.0001125737,0.00008570395],"domain_scores_gemma":[0.9984331,0.0002855413,0.000243861,0.0002343063,0.000207348,0.0005958297],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7377995,0.02078984,0.0939403,0.001074866,0.007041095,0.0006335333,0.0006635409,0.002231217,0.03741792,0.0002254363,0.004849384,0.09333327],"study_design_scores_gemma":[0.3646708,0.3381937,0.2700334,0.00007657007,0.005460594,0.001119112,0.0002310021,0.002485699,0.005046033,0.0003592945,0.01226127,0.00006244724],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9914728,0.001196595,0.001311116,0.0002058578,0.00005113193,0.00339882,0.00138307,0.00004795308,0.000932585],"genre_scores_gemma":[0.9839586,0.0006491612,0.00482526,0.000582659,0.00007974161,0.003239009,0.005057532,0.00003018121,0.001577855],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004955627,"threshold_uncertainty_score":0.02620816,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05034906859150347,"score_gpt":0.3679076374841846,"score_spread":0.3175585688926811,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}